dorsaVi ViMove being used to identify Adolescent Idiopathic Scoliosis
CLICK HERE TO CONTACT dorsaVi

Melbourne, Australia.  9 August 2016.  This week at the 40th Annual Meeting of the American Society of Biomechanics, Dr Michael De Gregorio, Ph.D., research engineer in the orthopaedics department at Wake Forest Baptist Medical Center, presented the first stage of this research titled, “Seated postural differences between children with and without adolescent idiopathic scoliosis: a pilot study.” These findings present opportunities for both early identification and potential prevention of Adolescent Idiopathic Scoliosis (AIS).

 Scoliosis is an abnormal curvature of the spine that can lead to life-long pain and disability and affects 7 million children in the US. The key to preventing severe deformity in AIS is early diagnosis. The current treatment for moderate and severe scoliosis is long-term bracing and surgery.

The initial research describes dorsaVi ViMove as being able to identify lower back movement patterns and differences between adolescents with scoliosis and those without. Understanding these differences allows the opportunity to study possible early stage posture treatments as an intervention.
 
As evidenced in previous chronic low back pain literature (Kent P, 2015, BMC Musculoskeletal J), the use of the data from the dorsaVi ViMove system has been shown to modify patient’s movement patterns and lead to sustained long term improvements in pain (45% reduction) and function (73% improvement). This previous research was conducted on people with chronic long term back pain, however the findings of the Wake Forest Baptist research are encouraging and suggest that similar dorsaVi ViMove treatments may be effective in assisting other serious spinal conditions.
 
dorsaVi is excited to be working with world leading medical researchers in this important project aiming to improve the health outcomes and quality of life for adolescents with this challenging spinal condition.

– END –

Melbourne, Australia.  9 August 2016.  This week at the 40th Annual Meeting of the American Society of Biomechanics, Dr Michael De Gregorio, Ph.D., research engineer in the orthopaedics department at Wake Forest Baptist Medical Center, presented the first stage of this research titled, “Seated postural differences between children with and without adolescent idiopathic scoliosis: a pilot study.” These findings present opportunities for both early identification and potential prevention of Adolescent Idiopathic Scoliosis (AIS).

 Scoliosis is an abnormal curvature of the spine that can lead to life-long pain and disability and affects 7 million children in the US. The key to preventing severe deformity in AIS is early diagnosis. The current treatment for moderate and severe scoliosis is long-term bracing and surgery.

The initial research describes dorsaVi ViMove as being able to identify lower back movement patterns and differences between adolescents with scoliosis and those without. Understanding these differences allows the opportunity to study possible early stage posture treatments as an intervention.

As evidenced in previous chronic low back pain literature (Kent P, 2015, BMC Musculoskeletal J), the use of the data from the dorsaVi ViMove system has been shown to modify patient’s movement patterns and lead to sustained long term improvements in pain (45% reduction) and function (73% improvement). This previous research was conducted on people with chronic long term back pain, however the findings of the Wake Forest Baptist research are encouraging and suggest that similar dorsaVi ViMove treatments may be effective in assisting other serious spinal conditions.

dorsaVi is excited to be working with world leading medical researchers in this important project aiming to improve the health outcomes and quality of life for adolescents with this challenging spinal condition.

– END –

Request more information about our technology

CONTACT ME FOR MORE INFORMATION

Randomised Controlled Trial with dorsaVi technology finds back pain patients monitored and treated using dorsaVi's sensors had significant, sustained improvements in pain and function.

Recent news: What's happening at dorsaVi 

ViPerform and the NFL: How Loren Landow uses objective data to assess risk of injury

Fix the following errors:
Hide